Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
1047-1246 |
Epistemic_statement |
denotes |
These results demonstrate the important role of miR-26a in modulating PRRSV infection and also support the possibility of using host miR-26a to achieve RNAi-mediated antiviral therapeutic strategies. |
T2 |
2008-2237 |
Epistemic_statement |
denotes |
Host miRNAs can affect viral replication by binding directly to viral RNA (Lecellier et al., 2005) or by indirectly modulating host factors to provide a less permissive environment for virus replication (Triboulet et al., 2007) . |
T3 |
2238-2383 |
Epistemic_statement |
denotes |
As miRNAs are small molecules without antigenic properties, they are considered to have potential efficacy in antiviral therapeutic applications. |
T4 |
3254-3440 |
Epistemic_statement |
denotes |
Many strategies for controlling PRRSV transmission have been proposed but have generally shown little success, which has stimulated the search for new ways to control PRRSV transmission. |
T5 |
3441-3534 |
Epistemic_statement |
denotes |
PRRSV can escape from innate immunity and cause persistent infections (Miller et al., 2004) . |
T6 |
3665-3921 |
Epistemic_statement |
denotes |
Type I interferons can initiate the activation of JAK/STAT signaling to induce the expression of hundreds of IFN-stimulated genes (ISGs), which play an important role in antiviral activities (Albina et al., 1998; Katze et al., 2002; Overend et al., 2007) . |
T7 |
3922-4032 |
Epistemic_statement |
denotes |
However, in contrast to porcine respiratory coronavirus, PRRSV is a poor IFN-inducer (Buddaert et al., 1998) . |
T8 |
4414-4554 |
Epistemic_statement |
denotes |
Recent research has revealed that miR-23 may play a positive modulatory role in IFN production during PRRSV infection (Zhang et al., 2014) . |
T9 |
5081-5244 |
Epistemic_statement |
denotes |
Our study reveals an example of a miRNA that affects viral propagation and highlights a host factor that may be important for future control measures against PRRS. |
T10 |
13191-13601 |
Epistemic_statement |
denotes |
To screen potential miRNAs for their ability to inhibit PRRSV replication, mimics of 15 miRNAs that are well-conserved among different species and have been previously implicated in innate immunity and/or antiviral functions (Banerjee et al., 2013; Foley and O'Neill, 2012; Huang et al., 2014; Yoo and Liu, 2013; Pauley and Chan, 2008; Schulte et al., 2013; Selvamani et al., 2014) were synthesized (Table 1) . |
T11 |
14016-14155 |
Epistemic_statement |
denotes |
1B) , indicating that miR-26 has antiviral activity against PRRSV replication and that miR-26a is a more efficient suppressor than miR-26b. |
T12 |
14424-14705 |
Epistemic_statement |
denotes |
To rule out the possibility that this antiviral effect of miR-26a was specific to an individual PRRSV strain, we analyzed the viral growth curves of two type 2 PRRSV strains (vJX143, vJXM100) and a type 1 PRRSV strain (vSHE) in MARC-145 cells transfected with NC or miR-26a mimics. |
T13 |
15323-15534 |
Epistemic_statement |
denotes |
To exclude the possibility that reduced PRRSV replication was due to potential toxicity of the miR-26a mimic, MARC-145 cells were transfected with the miR-26a mimic at different doses (40 nM, 80 nM, and 160 nM). |
T14 |
16047-16161 |
Epistemic_statement |
denotes |
As previously reported, miRNA-mRNA interactions may require seed-matched sites at nucleotides 2-8 (Bartel, 2009 ). |
T15 |
17549-17623 |
Epistemic_statement |
denotes |
Notably, miR-26a was more efficient suppressing viral growth than miR-26b. |
T16 |
17624-17735 |
Epistemic_statement |
denotes |
These results indicated that miR-26 family members, especially miR-26a, can inhibit vJX143 replication in PAMs. |
T17 |
17916-18072 |
Epistemic_statement |
denotes |
Targeting a specific viral sequence represents an efficient strategy by which miRNAs can inhibit viral replication (Jopling, 2010; Lecellier et al., 2005) . |
T18 |
18261-18654 |
Epistemic_statement |
denotes |
We determined whether miR-26a specifically targets the PRRSV genome to exert its antiviral effect by constructing a range of firefly luciferase reporter pGL3-Control based plasmids, which contained the cDNA fragments representing the 5 UTR, nsp1-nsp12, ORF2-ORF7, and the 3 UTR of the PRRSV genome Statistical significance was analyzed using t-tests; *, P < 0.05; **, P < 0.01; ***, P < 0.001. |
T19 |
19628-19770 |
Epistemic_statement |
denotes |
If the PRRSV cDNA insert contains a miR-26a target sequence, luciferase reporter expression is expected to be subjected to miR-26a-regulation. |
T20 |
20215-20281 |
Epistemic_statement |
denotes |
Thus, miR-26a does not appear to target directly the PRRSV genome. |
T21 |
22457-22618 |
Epistemic_statement |
denotes |
generated small RNA expression profiles at 12, 24 and 48 h post-infection to identify alterations in miRNA expression associated with PRRSV (Yoo and Liu, 2013) . |
T22 |
22732-22803 |
Epistemic_statement |
denotes |
However, in this study, miR-26a was not mentioned (Yoo and Liu, 2013) . |
T23 |
23088-23270 |
Epistemic_statement |
denotes |
However, PRRSV is a fast-evolving RNA virus (Prieto et al., 2009) and the relatively high mutation rate may limit the application of this kind of RNAi-mediated antiviral therapeutic. |
T24 |
23271-23368 |
Epistemic_statement |
denotes |
Cellular miRNAs can also indirectly modulate cellular pathways that perturb the viral life cycle. |
T25 |
23369-23579 |
Epistemic_statement |
denotes |
In particular, the activation or enhancement of innate antiviral immune pathways has been suggested to be responsible for the antiviral effect of certain miRNAs (Lecellier et al., 2005; Pedersen et al., 2007) . |
T26 |
23580-23721 |
Epistemic_statement |
denotes |
In the current study, the reduction of PRRSV replication by miR-26a did not appear to involve direct targeting of the PRRSV genomic RNA (Fig. |
T27 |
23900-24005 |
Epistemic_statement |
denotes |
These data led us to hypothesize that miR-26a might act on a cellular factor to reduce PRRSV replication. |
T28 |
24006-24159 |
Epistemic_statement |
denotes |
The results presented here support a link between PRRSV replication and the altered expression of miR-26a in targeting host innate immune responses (Fig. |
T29 |
24687-24879 |
Epistemic_statement |
denotes |
Overall, these analyses suggest that PRRSV subverts host defenses by inhibiting the expression of pro-inflammatory cytokines (Van Reeth et al., 1999) and stimulating weak production of IFN-␣ . |
T30 |
24880-25128 |
Epistemic_statement |
denotes |
Our results showed that over-expression of miR-26a was capable of inducing expression of IFN-␣/ and the IFN-stimulated genes ISG15 and MX1, which might result in activation of the IFN response and further lead to the inhibition of virus infection. |
T31 |
25129-25300 |
Epistemic_statement |
denotes |
The restoration of innate immune responses to produce type I IFNs in PAMs seems to be miRNA specific, because another miRNA (miR-181b) had no such effect (data not shown). |
T32 |
25301-25430 |
Epistemic_statement |
denotes |
Thus, it is possible that miR-26a-induced type I IFN expression can overcome PRRSV interference, contributing to viral clearance. |
T33 |
26445-26556 |
Epistemic_statement |
denotes |
Our results showed that miR-26a also can mediate the activation of IFNs in the absence of PRRSV infection (Fig. |
T34 |
26562-26775 |
Epistemic_statement |
denotes |
The possible causes may relate to recent studies about a new function of miRNAs, which is independent of their conventional role in post-transcriptional gene regulation Fabbri et al., 2012; Lehmann et al., 2012) . |
T35 |
27014-27114 |
Epistemic_statement |
denotes |
Although there is no current evidence, miR-26a may also serve as ligands for TLRs and activate IFNs. |
T36 |
27115-27192 |
Epistemic_statement |
denotes |
Future studies will be necessary to unravel the diverse functions of miR-26a. |
T37 |
27278-27575 |
Epistemic_statement |
denotes |
Although clearly defining the target and physiological role of miR-26a remains an unfinished task, our study provided evidence that over-expression of miR-26a enhances IFN-␣/ expression during PRRSV infection, suggesting that miR-26a could be used as a potential target for antiviral development. |